Mediclinic International PLC Holding(s) in Company (2484C)
April 12 2017 - 1:30AM
UK Regulatory
TIDMMDC
RNS Number : 2484C
Mediclinic International PLC
12 April 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
12 April 2017
Notification of Major Interest in Mediclinic International plc
shares
1. Identity of the issuer or Mediclinic International
the underlying issuer plc
of existing shares to which
voting rights are
attached:
----------------------------------------------------------- -----------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights x
------------------------------------------------------------ ----------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ ----------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ ----------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ ----------------------------
Other (please
specify):
---------------------------------------------------------- ----------------------------
3. Full name of person(s) Coronation Asset Management
subject to the (Pty) Ltd
notification obligation:
----------------------------------------------------------- -----------------------------
4. Full name of shareholder(s) N/A
(if different from 3.):
----------------------------------------------------------- -----------------------------
5. Date of the transaction 10 April 2017
and date on
which the threshold is
crossed or
reached:
----------------------------------------------------------- -----------------------------
6. Date on which issuer 11 April 2017
notified:
----------------------------------------------------------- -----------------------------
7. Threshold(s) that is/are
crossed or
reached: 5%
----------------------------------------------------------- -----------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ----------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights
Shares Voting rights
Rights
------------- ----------------- ---------------- -------------- ----------------------- -------------------------
Direct Direct Indirect Direct Indirect
------------- ------------- ------------ -------------- --------- ------------ ------------ -----------
36 852 36 852 37 677 37 677
GB00B8HX8Z88 189 189 189 189 5.11%
----------------- ---------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument Period may be
acquired if
the
instrument
is
exercised/
converted.
----------------- --------------- -------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights
instrument period refers to
--------------- --------------- -------------- ---------------- ------------------------- -----------------------
Nominal Delta
--------------- --------------- -------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
37 677 189 5.11%
---------------------------------------------------- ----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
-------------------------------------------------------------------
Proxy Voting:
-------------------------------------------------------------------
10. Name of the proxy holder: Coronation Asset Management
(Pty) Ltd
------------------------------------- ----------------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------- ----------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------- ----------------------------
13. Additional information:
------------------------------------- ----------------------------
14. Contact name: Jamie Rowland
------------------------------------- ----------------------------
15. Contact telephone number: +27 21 680 2000
------------------------------------- ----------------------------
Mediclinic's primary listing is on the Main Market of the LSE,
with secondary listings on the JSE in South
Africa and on the NSX in Namibia.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH,
United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAANRBSASAAR
(END) Dow Jones Newswires
April 12, 2017 02:30 ET (06:30 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024